Selected ressource details

Back

Psychedelic to Treat Depression in Alzheimer's, BMND08, to Enter Trial

blog Post

2022

Patricia, Iniaco

Biomind Labs plans to open a Phase 2 trial of BMND08, its oral psychedelic-based therapy, to treat depression and anxiety in Alzheimer’s.